CO7141413A2 - Proceso para la preparación de derivados de 2-(1-hidroxi-alquil)-cromen-4-ona ópticamente puros y opcionalmente sustituidos y su uso en la preparación de compuestos farmacéuticos - Google Patents

Proceso para la preparación de derivados de 2-(1-hidroxi-alquil)-cromen-4-ona ópticamente puros y opcionalmente sustituidos y su uso en la preparación de compuestos farmacéuticos

Info

Publication number
CO7141413A2
CO7141413A2 CO14266920A CO14266920A CO7141413A2 CO 7141413 A2 CO7141413 A2 CO 7141413A2 CO 14266920 A CO14266920 A CO 14266920A CO 14266920 A CO14266920 A CO 14266920A CO 7141413 A2 CO7141413 A2 CO 7141413A2
Authority
CO
Colombia
Prior art keywords
preparation
chromen
hydroxy
alkyl
derivatives
Prior art date
Application number
CO14266920A
Other languages
English (en)
Inventor
Jayaraman Venkat Raman
Swaroop Kumar Venkata Satya Vakkalanka
Original Assignee
Rhizen Pharmaceuticals S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54193684&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO7141413(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhizen Pharmaceuticals S A filed Critical Rhizen Pharmaceuticals S A
Publication of CO7141413A2 publication Critical patent/CO7141413A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)

Abstract

La presente invención hace referencia a compuestos útilescomo intermedios farmacéuticos, a procesos para lapreparación de intermedios, a intermedios utilizados en losprocesos y al uso de los intermedios en la preparación decompuestos farmacéuticos. En particular, la presenteinvención comprende los derivados de 2-(1-hidroxi-alquil)-cromen-4-ona enantioméricamente puros y opcionalmentesustituidos representados mediante las fórmulas (IA) y (IB),los procesos para preparar los derivados de alcohol y su usoen la preparación de compuestos farmacéuticos.
CO14266920A 2012-05-04 2014-12-03 Proceso para la preparación de derivados de 2-(1-hidroxi-alquil)-cromen-4-ona ópticamente puros y opcionalmente sustituidos y su uso en la preparación de compuestos farmacéuticos CO7141413A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1737CH2012 2012-05-04
US201261671956P 2012-07-16 2012-07-16

Publications (1)

Publication Number Publication Date
CO7141413A2 true CO7141413A2 (es) 2014-12-12

Family

ID=54193684

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14266920A CO7141413A2 (es) 2012-05-04 2014-12-03 Proceso para la preparación de derivados de 2-(1-hidroxi-alquil)-cromen-4-ona ópticamente puros y opcionalmente sustituidos y su uso en la preparación de compuestos farmacéuticos

Country Status (25)

Country Link
US (1) US9309216B2 (es)
EP (1) EP2844647B1 (es)
JP (2) JP6290186B2 (es)
KR (1) KR102073181B1 (es)
CN (2) CN104507922B (es)
AP (1) AP3547A (es)
AU (1) AU2013255469B2 (es)
BR (1) BR112014027470A2 (es)
CA (1) CA2871000C (es)
CL (1) CL2014002986A1 (es)
CO (1) CO7141413A2 (es)
CY (1) CY1123456T1 (es)
EA (1) EA032812B1 (es)
HK (1) HK1203964A1 (es)
IL (1) IL235181A (es)
MX (1) MX365250B (es)
MY (1) MY171207A (es)
NZ (1) NZ701198A (es)
PH (1) PH12014502453A1 (es)
PL (1) PL2844647T3 (es)
RS (1) RS61035B1 (es)
SG (1) SG11201407184PA (es)
SI (1) SI2844647T1 (es)
WO (1) WO2013164801A1 (es)
ZA (1) ZA201407769B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102012398B1 (ko) 2009-11-05 2019-08-20 리젠 파마슈티컬스 소시에떼 아노님 신규한 벤조피란 키나제 조절제
US10130635B2 (en) 2012-05-04 2018-11-20 Rhizen Pharmaceuticals Sa Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals
PL2844647T3 (pl) * 2012-05-04 2021-01-25 Rhizen Pharmaceuticals S.A. Nowy sposób wytwarzania czystych optycznie i opcjonalnie podstawionych pochodnych 2-(1-hydroksyalkilo)-chromen-4-onu i ich zastosowanie do wytwarzania środków farmaceutycznych
CA2913226C (en) 2013-06-07 2023-01-03 Rhizen Pharmaceuticals Sa Dual selective pi3 delta and gamma kinase inhibitors
KR20170016489A (ko) * 2014-06-27 2017-02-13 리젠 파마슈티컬스 소시에떼 아노님 Pi3 델타 및 감마 단백질 키나제의 선택적 이중 저해제로서 치환된 크로멘 유도체
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EP3325462A4 (en) * 2015-07-23 2019-06-19 Pharmakea, Inc. INHIBITORS OF LYSYL OXIDASE-LIKE 2 AND USES OF SAID INHIBITORS
CA3013917A1 (en) 2016-02-09 2017-08-17 Pharmakea, Inc. Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2023130334A1 (zh) * 2022-01-07 2023-07-13 同润生物医药(上海)有限公司 一种色烯-4-酮化合物及其中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62201882A (ja) * 1985-11-18 1987-09-05 Yamanouchi Pharmaceut Co Ltd イソフラボン誘導体
PE20060426A1 (es) * 2004-06-02 2006-06-28 Schering Corp DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa
KR102012398B1 (ko) 2009-11-05 2019-08-20 리젠 파마슈티컬스 소시에떼 아노님 신규한 벤조피란 키나제 조절제
MX365160B (es) * 2011-05-04 2019-05-24 Rhizen Pharmaceuticals Sa Compuestos novedosos como moduladores de proteína cinasas.
PL2844647T3 (pl) * 2012-05-04 2021-01-25 Rhizen Pharmaceuticals S.A. Nowy sposób wytwarzania czystych optycznie i opcjonalnie podstawionych pochodnych 2-(1-hydroksyalkilo)-chromen-4-onu i ich zastosowanie do wytwarzania środków farmaceutycznych
DK3260455T3 (da) * 2012-07-04 2019-06-11 Rhizen Pharmaceuticals S A Selektive pi3k delta-hæmmere

Also Published As

Publication number Publication date
EP2844647A1 (en) 2015-03-11
EP2844647B1 (en) 2020-07-22
MY171207A (en) 2019-10-02
AU2013255469B2 (en) 2017-10-12
CA2871000A1 (en) 2013-11-07
CN104507922B (zh) 2018-02-09
SG11201407184PA (en) 2014-12-30
RS61035B1 (sr) 2020-12-31
HK1203964A1 (en) 2015-11-06
CN104507922A (zh) 2015-04-08
US9309216B2 (en) 2016-04-12
PH12014502453B1 (en) 2015-03-16
US20150087699A1 (en) 2015-03-26
AP3547A (en) 2016-01-14
NZ701198A (en) 2016-09-30
MX2014013426A (es) 2015-05-11
JP2015515975A (ja) 2015-06-04
KR102073181B1 (ko) 2020-02-04
BR112014027470A2 (pt) 2017-06-27
JP6290186B2 (ja) 2018-03-07
CN108084138A (zh) 2018-05-29
AU2013255469A1 (en) 2014-11-13
SI2844647T1 (sl) 2020-12-31
CY1123456T1 (el) 2022-03-24
WO2013164801A1 (en) 2013-11-07
JP2018039849A (ja) 2018-03-15
MX365250B (es) 2019-05-28
AP2014008087A0 (en) 2014-11-30
IL235181A (en) 2017-12-31
CL2014002986A1 (es) 2015-01-09
CA2871000C (en) 2021-10-19
KR20150006876A (ko) 2015-01-19
PL2844647T3 (pl) 2021-01-25
EA032812B1 (ru) 2019-07-31
EA201491818A1 (ru) 2015-04-30
PH12014502453A1 (en) 2015-03-16
ZA201407769B (en) 2016-05-25

Similar Documents

Publication Publication Date Title
CO7141413A2 (es) Proceso para la preparación de derivados de 2-(1-hidroxi-alquil)-cromen-4-ona ópticamente puros y opcionalmente sustituidos y su uso en la preparación de compuestos farmacéuticos
CR11623A (es) Compuestos
ECSP14006132A (es) Derivados de ácido benzotiazol-6-il acético y su uso para tratar una infección por vih
CU24272B1 (es) Derivados de tetrahidropirido-pirimidina como inhibidores de mek
ECSP14004812A (es) Triazolopiridinas sustituidas
CO6771439A2 (es) Inhibidores de benzodioxano de la producción de leucotrieno
ECSP14013215A (es) Compuestos novedosos
ECSP13012770A (es) Formas cristalinas de 5-cloro-n2-(2-isopropoxi-5-metil-4-piperidin-4-il-fenil)-n4-[2-(propan-2-sulfonil)-fenil]-pirimidin-2,4-diamina
CO6640270A2 (es) Morfolinopirimidad y su uso en terapia
UY33337A (es) DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS
ECSP14026138A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
EA201391313A1 (ru) C4-монометилтритерпеноидные производные и способы их применения
CR20140554A (es) Compuestos de acido dimetil-benzoico
CR20140175A (es) Compuestos y métodos para mejorar las respuestas inmunitarias innatas
CL2015001319A1 (es) Compuestos derivados de n-(piridin-2-il)pirimidin-4-amina que contienen un grupo sulfoximina; compuestos intermediarios; composicion farmaceutica; combinacion farmaceutica; y metodo para la preparacion de compuestos.
BR112013016863A2 (pt) processo para produzir um polistereterol
ECSP13012914A (es) Síntesis de derivados de 2-carboxamida-cicloamino-urea
CU20110108A7 (es) [4-(1-amino-etil)-ciclohexil]-metil-aminas como antibacterianos
CR20150160A (es) Derivados de macrólidos, su preparación y su uso terapéutico
PA8728901A1 (es) Metodos para preparar derivados de acido glutamico e intermediarios del mismo
DOP2013000284A (es) Derivados de pirazol útiles como inhibidores de aldosterona sintasa
AR102569A1 (es) Síntesis de inhibidor de pi3k, formas cristalinas y sales del mismo y una composición farmacéutica que lo comprende
CR20120109A (es) Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CU20100158A7 (es) Pirrolo[2,3-d]pirimidinas y usos de las mismas como inhibidores de cinasa de tirosina
UY31289A1 (es) Nuevos derivados de la quinoliniloxipiperidina y pirrolidina, su preparacion, composiciones farmaceuticas que los contiene y sus usos en el tratamieno de enfermedades